Octane EXO Inc.


Advanced biomaterials for spinal reconstruction and bone grafts




Seeking commercialization partner for spinal and bone graft applications

The scientists and engineers in our Octane EXO venture continue to push boundaries with active biocomposites engineered to integrate fully into skeletal implantation sites, particularly in spinal reconstruction.

Innovations in orthopedic implants have focused largely on improving material strength, durability, and biocompatibility to minimize negative biological consequences. In contrast, our proprietary formulations are biologically active, enabling progressive replacement of the implant with natural bone to generate a stable and robust biological interface. The addition of molecular peptides further stimulate bone tissue growth with the goal of enhanced clinical outcomes

Octane EXO is now preparing regulatory submissions directed at international markets and is actively seeking global partners for market delivery following regulatory approval.